The US health regulator has pulled up Jagsonpal Pharmaceuticals for significant manufacturing lapses at its Rajasthan-based ...

USFDA issues warning letter to Jagsonpal Pharmaceuticals for manufacturing lapses at Rajasthan plant, demands corrective ...

The USFDA has issued a warning letter to Jagsonpal Pharmaceuticals for significant manufacturing lapses at its ...

Jagsonpal Pharmaceuticals has received a warning from the USFDA for significant manufacturing lapses at its API plant in Rajasthan. The US regulator cites deviations from Good Manufacturing Practice, ...

For its entry into fast growing peptide segment and strengthen its CDMO biz ...